Daishin Chemical Co.,Ltd. (4629.T)
JPY 1372.0
(2.01%)
JPY 1372.0
(2.01%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | -185.13 Million | 1.79 Billion | 60.43 Million | 1.58 Billion | 2.66 Billion |
| Net Income | 936.58 Million | 1.3 Billion | 1.03 Billion | 1.67 Billion | 1.1 Billion |
| Depreciation & Amortization | 407.24 Million | 367.03 Million | 379.42 Million | 363.98 Million | 323.37 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | -1.05 Billion | 342.05 Million | -742.34 Million | 102.22 Million | 1.09 Billion |
| Other non-cash items | -66.18 Million | -23.71 Million | -16.87 Million | -14.12 Million | 14.74 Million |
| Investing Cash Flow | -438.9 Million | -414.3 Million | -333.28 Million | -569.27 Million | -100.49 Million |
| Investments in PPE | -501.93 Million | -345.63 Million | -263.23 Million | -470.82 Million | -275.2 Million |
| Acquisitions | 10.12 Million | -86.11 Million | 3.63 Million | 2.72 Million | 4.53 Million |
| Investment purchases | -171.29 Million | -94.35 Million | -88.42 Million | -84.5 Million | -138.39 Million |
| Sales/Maturities of investments | 220.71 Million | 8.87 Million | 7.8 Million | 26.01 Million | 309.97 Million |
| Other Investing Activities | 323 Thousand | 9.9 Million | 70 Thousand | 159 Thousand | -1.4 Million |
| Financing Cash Flow | -220.4 Million | -263.6 Million | -301.03 Million | -332.96 Million | -385.89 Million |
| Debt repayment | -20 Million | -110 Million | -122.6 Million | -163.6 Million | -248.6 Million |
| Dividends payments | -183 Million | -146.4 Million | -178.43 Million | -169.28 Million | -137.25 Million |
| Common Stock Repurchased | -31 Thousand | - | - | -76 Thousand | -34 Thousand |
| Common Stock Issuance | - | 2.4 Million | - | - | - |
| Other Financing Activities | -398 Thousand | -199 Thousand | - | -1000.00 | -1000.00 |
| Accounts receivables | -434 Million | 144 Million | -2.41 Billion | 418.79 Million | 1.92 Billion |
| Accounts payables | -312.3 Million | -89.64 Million | 2.33 Billion | -331.88 Million | -1.21 Billion |
| Inventory | 30.56 Million | -2.93 Million | -391.24 Million | 27.5 Million | 62.63 Million |
| Other working capital | -194 Million | 175 Million | -261.76 Million | -12.18 Million | 323.26 Million |
| Cash at beginning of period | 4.95 Billion | 3.83 Billion | 4.4 Billion | 3.71 Billion | 1.53 Billion |
| Cash at end of period | 4.1 Billion | 4.95 Billion | 3.83 Billion | 4.4 Billion | 3.71 Billion |
| Capital Expenditure | -501.93 Million | -345.63 Million | -263.23 Million | -470.82 Million | -275.2 Million |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -844.44 Million | 1.12 Billion | -573.88 Million | 687.22 Million | 2.18 Billion |
| Free Cash Flow | -687.07 Million | 1.45 Billion | -202.8 Million | 1.11 Billion | 2.39 Billion |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 65 Million | 180 Million | 936.58 Million | 92 Million | 280 Million | 75 Million |
| Depreciation & Amortization | - | - | 407.24 Million | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | -1.05 Billion | - | - | - |
| Other non-cash items | -65 Million | -180 Million | -66.18 Million | -92 Million | -280 Million | -75 Million |
| Investing Cash Flow | - | - | -438.9 Million | - | - | - |
| Investments in PPE | - | - | -501.93 Million | - | - | - |
| Acquisitions | - | - | 10.12 Million | - | - | - |
| Investment purchases | - | - | -171.29 Million | - | - | - |
| Sales/Maturities of investments | - | - | 220.71 Million | - | - | - |
| Other Investing Activities | - | - | 323 Thousand | - | - | - |
| Financing Cash Flow | - | - | -220.4 Million | - | - | - |
| Debt repayment | - | - | -20 Million | - | - | - |
| Dividends payments | - | - | -183 Million | - | - | - |
| Common Stock Repurchased | - | - | -31 Thousand | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | -398 Thousand | - | - | - |
| Accounts receivables | - | - | -434 Million | - | - | - |
| Accounts payables | - | - | -312.3 Million | - | - | - |
| Inventory | - | - | 30.56 Million | - | - | - |
| Other working capital | - | - | -194 Million | - | - | - |
| Cash at beginning of period | - | - | 4.95 Billion | - | - | - |
| Cash at end of period | - | - | 4.1 Billion | - | - | - |
| Capital Expenditure | - | - | -501.93 Million | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | -844.44 Million | - | - | - |
| Free Cash Flow | - | - | -687.07 Million | - | - | - |
2418
ALANKIT
CCK
SNK
3512
8418